Pembrolizumab,Lenvatinib,Sunitinib
Merck,Pfizer,eisai
['lenva', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'improve ', 'pembro']
the #oncoalerttoptweet #esmo22 day 3 tweet by our oncoalert colleague clear ph3 trial update: lenvatinib+pembrolizumab continues to significantly improve pfs sunitinib in mrcc #kidneycancer 23 vs 9.3 months. best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??